XML 46 R32.htm IDEA: XBRL DOCUMENT v3.24.3
Liquidity (Details) - USD ($)
2 Months Ended 12 Months Ended
Nov. 01, 2019
Sep. 10, 2024
Jun. 30, 2024
Jun. 30, 2024
Jun. 30, 2023
Liquidity          
Accumulated deficit     $ 139,374,895 $ 139,374,895 $ 131,080,749
Net loss       8,294,146 8,588,573
Net cash used in operating activities       6,315,507 5,670,051
Revenue       0  
Cash and cash equivalents     4,797,778 4,797,778 8,149,808
Liabilities     1,358,776 1,358,776 2,034,250
Accrued expenses     262,467 262,467 143,760
Line of credit     $ 3,000,000 3,000,000  
Net proceeds from sale of common stock       3,120,037  
Subsequent event          
Liquidity          
Issuance of shares   772,836      
Average price   $ 1.98      
Net proceeds from sale of common stock   $ 1,533,000      
ATM Offering          
Liquidity          
Gross proceeds       $ 3,237,000  
Issuance of shares     1,308,651    
Average price     $ 2.47 $ 2.47  
ATM Offering | Subsequent event          
Liquidity          
Gross proceeds   $ 1,500,000      
Average price   $ 1.98      
Nonrelated party          
Liquidity          
Accounts payable     $ 376,270 $ 376,270 157,056
Related party          
Liquidity          
Accounts payable     720,039 720,039 233,434
TheraCour Pharma Inc | Related party          
Liquidity          
Accounts payable     $ 720,039 $ 720,039 $ 233,434
Issuance of shares 75,000